Tag: Protein kinase inhibitors

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Protein kinase inhibitors

Roche's inavolisib combination reduces the risk of disease progression by 57% in ... - Yahoo Finance

Added to Collection on: 2023-12-08 22:22:09

Tags for this article:

Amides
Specialty drugs
Aminopyridines
Breakthrough therapy
Protein kinase inhibitors
Palbociclib
Phosphoinositide 3-kinase inhibitor
Alpelisib
Fulvestrant
Breast cancer
Triple-negative breast cancer
PI3K/AKT/mTOR pathway
F. Hoffmann-La Roche
San Antonio
Roche Group

Click the tags to see associated articles and topics

View Article Details
Inavolisib Plus Palbociclib and Fulvestrant Improves PFS in PIK3CA-Mutated HR+ Breast Cancer

Added to Collection on: 2023-12-08 18:14:54

Tags for this article:

Aminopyridines
Protein kinase inhibitors
Breakthrough therapy
Amides
Palbociclib
Fulvestrant
Genentech
Breast cancer
HER2
Inavolisib
Buparlisib
Phosphoinositide 3-kinase inhibitor

Click the tags to see associated articles and topics

View Article Details
BerGenBio commences Phase IIa portion of bemcentinib trial for NSCLC

Added to Collection on: 2024-03-21 16:52:18

Tags for this article:

Lung cancer
Protein kinase inhibitors
Tyrosine kinase receptors
Antineoplastic drugs
Orphan drugs
AXL receptor tyrosine kinase
Bemcentinib
Non-small-cell lung cancer
Pembrolizumab

Click the tags to see associated articles and topics

View Article Details
Roche (RHHBY) Cancer Drug Gets Breakthrough Therapy Designation - Yahoo Finance

Added to Collection on: 2024-05-21 17:16:29

Tags for this article:

Cyclopentanes
Specialty drugs
Protein kinase inhibitors
Antineoplastic drugs
Amides
Trastuzumab emtansine
Inavolisib
Palbociclib
Fulvestrant
Breast cancer
Trastuzumab
Ribociclib

Click the tags to see associated articles and topics

View Article Details
Promising Outlook for Olema Pharmaceuticals' OP-2313 as KAT6 Inhibitor Shows Efficacy in ...

Added to Collection on: 2024-06-04 19:40:10

Tags for this article:

Protein kinase inhibitors
Cyclopentanes
Pyridines
Pyrimidines
Ribociclib
Fulvestrant
Targeted therapy
Olema Pharmaceuticals
olema pharmaceuticals inc

Click the tags to see associated articles and topics

View Article Details
AstraZeneca's Truqap Flops in Phase III Triple-Negative Breast Cancer Trial | BioSpace

Added to Collection on: 2024-06-18 13:22:08

Tags for this article:

Breast cancer
Tyrosine kinase receptors
Protein kinase inhibitors
Aminopyridines
PI3K/AKT/mTOR pathway
Signal transduction
Triple-negative breast cancer
Protein kinase B
Capivasertib
Epidermal growth factor receptor
HER2
Fulvestrant

Click the tags to see associated articles and topics

View Article Details
The effect of ribociclib on the expression levels of miR-141 and CDK4/6-USP51 signaling ...

Added to Collection on: 2024-08-28 18:43:56

Tags for this article:

Protein kinase inhibitors
Cyclopentanes
Antineoplastic drugs
Cancer treatments
Cyclin-dependent kinase 4
Ribociclib
Chemotherapy
Radiation therapy
Cancer
CDK inhibitor
Triple-negative breast cancer

Click the tags to see associated articles and topics

View Article Details
Novartis' Kisqali gets expanded FDA OK; Mene Pangalos joins Omega Funds

Added to Collection on: 2024-09-18 16:53:06

Tags for this article:

Cyclopentanes
Protein kinase inhibitors
CYP3A4 inhibitors
Novartis
gsk plc
Boehringer Ingelheim
Pfizer
Ribociclib
Palbociclib

Click the tags to see associated articles and topics

View Article Details
Roche announces phase III INAVO120 results were published | Markets Insider

Added to Collection on: 2024-10-31 19:45:26

Tags for this article:

Antiestrogens
Cyclopentanes
Lactams
Protein kinase inhibitors
Antineoplastic drugs
Inavolisib
Palbociclib
Fulvestrant
Genentech
Breast cancer
HER2
Roche

Click the tags to see associated articles and topics

View Article Details
Study Shows Real-World Outcomes of First-Line Palbociclib Plus Fulvestrant in HR+, HER2

Added to Collection on: 2025-01-19 03:05:37

Tags for this article:

Cyclopentanes
Lactams
Selective estrogen receptor degraders
Protein kinase inhibitors
Antiestrogens
Palbociclib
Fulvestrant
Breast cancer
HER2
CDK inhibitor
Dalpiciclib
Pfizer
AstraZeneca

Click the tags to see associated articles and topics

View Article Details